Revenue
No reported data
Corvus Pharmaceuticals, Inc. (CRVS)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2019
2020
2021
2022
2023
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & development | $33.7M | $19.4M | $16.5M | $24.5M | $29.1M | $31.8M | $38.0M | $38.6M | $46.3M | $29.4M | $11.4M | $38,000 |
| Operating expenses | $43.0M | $27.5M | $23.4M | $32.6M | $38.6M | $43.8M | $48.9M | $49.2M | $56.5M | $37.0M | $13.8M | — |
| Operating income | −$43.0M | −$27.5M | −$23.4M | −$32.6M | −$38.6M | −$43.8M | −$48.9M | −$49.2M | −$56.5M | −$37.0M | −$13.8M | −$161,000 |
| EBITDAderived | −$42.9M | −$27.5M | −$23.3M | −$32.2M | −$38.2M | −$43.1M | −$48.1M | −$48.4M | −$55.7M | −$36.4M | −$13.6M | — |
| Net income | −$15.3M | −$62.3M | −$27.0M | −$41.3M | −$43.2M | −$6.0M | −$46.7M | −$46.9M | −$55.7M | −$36.4M | −$31.3M | −$161,000 |
| Basic EPSper diluted share | -$0.19 | -$1.02 | -$0.56 | -$0.89 | -$1.03 | -$0.20 | -$1.59 | -$1.71 | -$2.72 | -$2.36 | -$83.86 | -$0.95 |
| Diluted EPSper diluted share | -$0.53 | -$1.02 | -$0.56 | -$0.89 | -$1.03 | -$0.20 | -$1.59 | -$1.71 | -$2.72 | -$2.36 | -$83.86 | -$0.95 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 11, 2026Form 4 | Moore David ScottDirector | BuyCommon Stock | 21.7K | $11.53 | $250.2K | 21.7K |
| May 18, 2026Form 4 | MILLER RICHARD A MDPresident and CEO | BuyCommon Stock · indirect | 1.9K | $12.01 | $23.2K | 1.20M |
| May 18, 2026Form 4 | MILLER RICHARD A MDPresident and CEO | BuyCommon Stock · indirect | 5.0K | $12.05 | $60.3K | 1.19M |
| Jun 27, 2025Form 4 | ORBIMED ADVISORS LLC +1Director,TenPercentOwner | SellCommon Stock · indirect | 1.18M | $4.16 | $4.89M | 7.17M |
| Jun 27, 2025Form 4 | Thompson Peter A.Director,TenPercentOwner | SellCommon Stock · indirect | 1.18M | $4.16 | $4.89M | 7.17M |